Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Fox who wrote (1308)	4/9/1998 12:00:00 PM
From: D.Right	Read Replies (1) \| Respond to of 2173

Dear Bill: Very interesting. I remember about half year ago a similar report said about the same thing, but I don't know whether it was the same group or not but it was backed by LLY. It should be great news for diabetes patients. The C peptide is, of course, a peptide hormone just like insulin and amylin. Exciting as it is, there are still a lot unknowns about it, and a very long development process to go through. Still it is good news. It also gave other hormone replacement therapy like amylin more credit. Good day. D.Right